Anti-D Rh0 immunoglobulin - Biotest

Drug Profile

Anti-D Rh0 immunoglobulin - Biotest

Alternative Names: Anti-D immune globulin - Biotest; Anti-D polyclonal antibody; Nabi Anti-D; Rh0 (D) Immune Globulin Intravenous (Human)

Latest Information Update: 29 May 2012

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nabi Biopharmaceuticals
  • Developer Biotest Pharmaceuticals
  • Class Immunoglobulins
  • Mechanism of Action Platelet activating factor stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Immune thrombocytopenic purpura

Most Recent Events

  • 31 Dec 2006 Phase-I clinical trials in Immune thrombocytopenic purpura in USA (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top